Additional file 2: of A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells Junko Matsuzaki Takemasa Tsuji Thinle Chodon Courtney Ryan Richard Koya Kunle Odunsi 10.6084/m9.figshare.7569725.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_of_A_rare_population_of_tumor_antigen-specific_CD4_CD8_double-positive__T_lymphocytes_uniquely_provide_CD8-independent_TCR_genes_for_engineering_therapeutic_T_cells/7569725 Intensity of HLA-A2 and NY-ESO-1 expression on A*02+NY-ESO-1+ cancer cell lines. Surface HLA-A2 (clone: BB7.2) and cytoplasmic NY-ESO-1 (clone: 219–510) expression was analyzed by flow cytometry. Shaded histogram is unstained control. (DOCX 88 kb) 2019-01-09 05:00:00 NY-ESO-1 TCR gene-engineering CD4+CD8+ double-positive T cells HLA-A*02:01 Anti-tumor function Adoptive cell therapy Ovarian cancer